Sign in

CIK 0001822462 · Non-accelerated filer<br>Smaller reporting company

Foghorn Therapeutics Inc.

Sign in to watch
Ticker
FHTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-586-3100
Business address
500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE, MA, 02139
  1. SC 13G Stake Amended Statement of Ownership
  2. 8-K Event Executive or director change
  3. 10-K Report Annual Report
  4. 8-K Event Results of operations
  5. 8-K Event Regulation FD disclosure
  6. SC 13G Stake Amended Statement of Ownership
  7. SC 13G Stake Amended Statement of Ownership
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. S-8 Other Securities Offered to Employees in Benefit Plans
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. 8-K Event Material agreement · New debt or obligation · Unregistered share sale
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  20. 4 Open-market buy Chief Scientific Officer bought 5,500 shares at $16.00 ($88,000)

Page 16 of 18 · 356 filings